Search results
How Drug Makers Manipulate Patents to Keep Insulin Prices High
Time via Yahoo News· 6 months agoCredit - UCG—Getty The financial burden of high insulin costs that patients and insurers face is...
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Zacks via Yahoo Finance· 1 month agoBausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced...
US FTC disputes over 100 medical patents listed with FDA including asthma inhalers
Reuters via Yahoo Finance· 6 months agoWASHINGTON (Reuters) -The U.S. Federal Trade Commission (FTC) on Tuesday said it sent letters to...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 3 weeks agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...
What Medicare beneficiaries need to know about generic medications
Fortune via Yahoo Finance· 6 days agoGeneric drugs save 43 million Medicare beneficiaries billions of dollars annually compared to the...
How sham patents are hurting the pharma industry
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoPatent protection enables pharmaceutical companies to manufacture and market novel drugs, ensuring they make an initial profit from their discoveries....
Avadel Pharmaceuticals Announces Favorable Ruling Regarding Sleep Disorder Drug Patent
Benzinga via Yahoo Finance· 1 year agoAvadel Pharmaceuticals plc (NASDAQ: AVDL) announced that the United States District Court for the...
Baldwin calls on drug companies to stop gaming patents for asthma inhalers
The Hill via Yahoo News· 4 months agoSen. Tammy Baldwin (D-Wis.) is demanding the four largest manufacturers of inhalers stop improperly...
‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’,...
Fortune via Yahoo Finance· 4 months agoIt’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’...
FDA Approves First Branded Ocular Anesthetic In Almost 14 Years
Benzinga via Yahoo Finance· 2 years agoThe FDA approved Harrow Health Inc (NASDAQ: HROW) and Sintetica S.A's Iheezo (chloroprocaine...
